Sign in
4

Changes in Ownership

Immuneering Corp Filed Acc 0001628280-24-028072

Options or other derivatives

  • Director acquired 8,588 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schall Thomas J. Director 2024-06-12 Grant or award · Stock Option +8,588 8,588 D: show line 1 in the form
Loading xslF345X05/wk-form4_1718310353.xml…